175406-94-7

Basic information

• Product Name: ethyl 1-benzyl-3-oxopiperidine-4-carboxylate hydrochloride
• Synonyms: ethyl 1-benzyl-3-oxopiperidine-4-carboxylate hydrochloride;Methyl 1-benzyl-3-oxopiperidine-4-carboxylate;Methyl 1-benzyl-3-oxo-4-piperidinecarboxylate
• CAS NO: 175406-94-7
• Molecular Formula: C₁₄H₁₇NO₃
• Molecular Weight: 297.7772
• Mol File: 175406-94-7.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ethyl 1-benzyl-3-oxopiperidine-4-carboxylate hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 1-benzyl-3-oxopiperidine-4-carboxylate hydrochloride(175406-94-7)
• EPA Substance Registry System: ethyl 1-benzyl-3-oxopiperidine-4-carboxylate hydrochloride(175406-94-7)

Safety Data

• Hazardous Substances Data: 175406-94-7(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 1-benzyl-3-oxopiperidine-4-carboxylate hydrochloride is used as a synthetic intermediate for the production of various medications, particularly those intended to act on the central nervous system. Its role as a building block in the synthesis of pharmaceutical drugs allows for the development of new chemical entities for drug discovery and development.
Used in Drug Synthesis:
Ethyl 1-benzyl-3-oxopiperidine-4-carboxylate hydrochloride is used as a precursor in the preparation of new chemical entities for drug discovery and development. Its unique structure and properties make it a valuable component in the synthesis of innovative pharmaceutical products.
Used in Pharmaceutical Formulation:
The hydrochloride form of ethyl 1-benzyl-3-oxopiperidine-4-carboxylate enhances its solubility and stability, making it easier to handle and formulate in pharmaceutical preparations. This improved formulation capability allows for more effective and efficient production of medications.

Upstream product

• 67-56-1 methanol 
• 39514-19-7 ethyl 1-benzyl-3-oxo-4-piperidinecarboxylate 
• 40114-49-6 1-benzyl-3-piperidone 
• 616-38-6 carbonic acid dimethyl ester 

Downstream Products

• 467250-42-6 7-benzyl-2-[(2-hydroxy-ethyl)-methyl-amino]-5,7,8,9-tetrahydro-6H-1,3,3a,7,9-pentaaza-cyclopenta[b]naphthalen-4-one 
• 1123784-57-5 methyl 3-amino-1-benzyl-1,2,5,6-tetrahydropyridine-4-carboxylate 
• 179023-37-1 methyl 3-hydroxypiperidine-4-carboxylate 
• 219975-81-2 1,1-dimethylethyl trans-3-hydroxy-4-(hydroxymethyl)-1-piperidinecarboxylate 
• 39478-61-0 trans-1-(phenylmethyl)-4-(hydroxymethyl)piperidin-3-ol 
• 1207853-61-9 (3R,4R)-3-amino-4-methylpiperidine-1-carboxylic acid tert-butyl ester 
• 374794-77-1 tert-butyl 4-methyl-3-oxopiperidine-1-carboxylate 
• 32018-96-5 1-benzyl-4-methyl-piperidin-3-one 
• 1312762-43-8 (3R,4R)-4-methyl-3-(methyl-((R)-1-phenylethyl)amino)piperidine-1-carboxylic acid tert-butyl ester 
• 1312762-44-9 (3R,4R)-3-methylamino-4-methylpiperidine-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

ISOXAZOLE CARBOXAMIDE COMPOUNDS AND USES THEREOF

A compound of Formula (I) or or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating hearing loss or balance disorder: Formula (I) wherein R1 and Y are as defined herein.

3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF

The present invention relates to compounds according to Formula (I) or a pharmaceutically acceptable salt or solvate thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.

HETEROCYCLIC MODULATORS OF TGR5

Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of modulation of TGR5 activity in a human or animal subject are also provided for the treatment diseases mediat